DeepMed Research

OPC-214870

Generic Name: OPC-214870

Clinical Trials

A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870

Phase 1

Completed

Conditions: Epilepsy

Interventions: Drug: OPC-214870
Other: Placebo

First Posted Date: 2020-01-27

Last Posted Date: 2022-08-24

Lead Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Target Recruit Count: 16

Registration Number: NCT04241965

Locations: 🇺🇸
For additional information regarding sites, contact 844-687-8522, Ormond Beach, Florida, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy